Bevacizumab for ROP

Ophthalmology

Volumn 119, Issue 2, 2012, Pages 431-432

  Blair, Michael ^a   Shapiro, Michael J ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; VASCULOTROPIN;

DISEASE COURSE; FOLLOW UP; HUMAN; LASER SURGERY; LETTER; MONOTHERAPY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RETINA DETACHMENT; RETROLENTAL FIBROPLASIA; TREATMENT OUTCOME;

ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL; DIFFUSION OF INNOVATION; HUMANS; NEOVASCULARIZATION, PATHOLOGIC; RETINOPATHY OF PREMATURITY;

EID: 84856521497     PISSN: 01616420     EISSN: 15494713     Source Type: Journal    
DOI: 10.1016/j.ophtha.2011.11.021     Document Type: Letter

References (2)

1. D.M. Moshfeghi, A.M. Berrocal Retinopathy of prematurity in the time of bevacizumab: incorporating the BEAT-ROP results into clinical practice Ophthalmology 118 2011 1227 1228
2. H.A. Mintz-Hittner, K.A. Kennedy, A.Z. Chuang BEAT-ROP Cooperative Group Efficacy of intravitreal bevacizumab for stage 3+ retinopathy of prematurity N Engl J Med 364 2011 603 615